Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Design strategies to maintain power in epidemiological malaria cluster randomised trials with large between cluster heterogeneity: a meta-analysis.
BIGGS, J; Challenger, J; Churcher, T; COOK, J;
2024
(2024).
Sustainable Development Goals' health-related indicators for Brazil and Ecuador: an analysis for the period of 1990-2019.
Malta, DC; Romero-Sandoval, N; Cardoso, LS D M; Arcos, P; Gualán, M; PESCARINI, JM; BRICKLEY, EB; Veloso, GA; Bernal, RT I; Gomes, CS; Kerr, LR F S; Naghavi, M; Cooper, PJ; Barreto, ML; Leyland, AH;
2024
Public health, (2024).231, 10.1016/j.puhe.2024.01.034.
The effect of RTS,S/AS01E and SMC alone or combined on the acquisition of blood stage antimalarial antibody responses.
PATTERSON, C; SOREMEKUN, S; Dicko, A; Ouedraogo, J-B; Zongo, I; Sagara, I; Snell, P; Lee, C; Ockenhouse, C; Ofori-Anyinam, O; Tinto, H; CHANDRAMOHAN, D; GREENWOOD, B; DRAKELEY, C;
2024
(2024).
Modelling the potential impact of perennial malaria chemoprevention with sulfadoxine pyrimethamine in Cameroon.
Atkinson, I; MOUSA, A; Ali, I; Winskill, P; Nji, A; Voundi, J; PITT, C; McGirr, A; MARTÍNEZ-VEGA, R; CHICO, RM; Beshir, KB; Chopo-Pizarro, A; Filtenborg-Hocke, E; Hansson, H; Alifrangis, M; Gosling, R; Mbacham, WF; ROPER, C; Okell, L;
2024
(2024).MH4 Category, Chemoprevention 1 Scientific Session N° 6
School-based malaria chemoprevention as a cost-effective approach to improve cognitive and educational outcomes: a meta-analysis.
Angrist, N; Jukes, MC H; CLARKE, S; CHICO, RM; OPONDO, C; Bundy, D; Cohee, LM;
2024
(2024).
Characterisation of Plasmodium falciparum antimalarial drug resistance marker profiles in polyclonal/mixed infections by Illumina targeted sequencing.
Chico, RM; Hansson, H; Pedersen-Ebbe Midtboell, M; Filtenborg Hocke, E; CHICO, RM; Beshir, KB; Chopo-Pizarro, A; MOUSA, A; SUTHERLAND, CJ; ROPER, C; Alifrangis, M;
2024
(2024).MH4 Category: Drug Resistance Scientific Session N° 56
Identification of the PfK13 mutations R561H and P441L in Democratic Republic of Congo (DRC): and a snapshot of prevalence and diversity at antimalarial drug resistance loci in P. falciparum across the DRC.
Kahunu, GM; Wellmann-Thomsen, S; Wellmann-Thomsen, L; Hypolite, MM; Patrick, MM; Filtenborg Hocke, E; CHICO, RM; Beshir, KB; SUTHERLAND, CJ; Chopo-Pizarro, A; Papy, MN; Baraka, V; Minja, DT R; MOUSA, A; Mbongi, MD; Mumba-Ngoyi, D; Mukomena Sompwe, D; Muyembe Tanfum, JJ; ROPER, C; Hansson, H; Alifrangis, M;
2024
(2024).MH4 Category: Drug Resistance 5 Scientific Session N° 56
Concurrent declines in malaria incidence among children under and over five years of age in Koutiala, Mali: time series analysis of seasonal malaria chemoprevention from 2012-2022.
Maiga, H; OPONDO, C; Cohee, LM; Coulibaly, O; Alaofari, M; CHICO, RM;
2024
(2024).MH4 Category: Drug Resistance 5 Scientific Session N° 56
Social determinants of malaria chemoprevention among children in sub-Saharan Africa: a systematic review.
Mosoff, JM; CHICO, RM; LAL, S;
2024
(2024).
Does the improved impact of dual active ingredient nets on malaria control last 3 years? Results from randomised controlled trials.
NGUFOR, C;
2024
(2024).